AQST vs AYTU โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AYTU Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AYTU BioPharma, Inc. Common Stock (AYTU) driven by superior Valuation, Growth & Margin, Options & Structure while AQST counters with relative strength in Momentum & Technical. Fundamentally, AQST trades at N/M Forward P/E with -114.1% operating margin (-41.0% YoY revenue) versus AYTU at 9.2x Forward P/E and -14.4% operating margin (+6.4% YoY). In options structure, AQST sits in BREAKDOWN (40th %ile IV; Dealer Gamma Walls on Pro) against AYTU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | AQST Revenue | AYTU Revenue | AQST Op. Margin | AYTU Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $50M | $10M | -100.1% | -230.1% | AQST |
| FY2020 | $50M | $30M | -93.6% | -76.5% | AYTU |
| FY2021 | $50M | $70M | -68.2% | -89.7% | AQST |
| FY2022 | $50M | $100M | -88.2% | -113.7% | AQST |
| FY2023 | $50M | $110M | -29.9% | -15.9% | AYTU |
| FY2024 | $60M | $70M | -53.5% | -2.4% | AYTU |
| FY2025 | $40M | $70M | -159.5% | -11.8% | AYTU |
| FY2026 | N/A | $60M | N/A | -14.4% | AYTU |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AQST | AYTU | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $448.7M | $19.6M | Larger Scale | AQST |
| Trailing P/E Ratio Valuation | N/M | 9.2x | Lower Multiple | AYTU |
| Forward P/E Ratio Valuation | N/M | 9.2x | Lower Multiple | AYTU |
| Revenue Growth (YoY) Growth | -41.0% | +6.4% | Higher Growth | AYTU |
| Operating Margin (TTM) Profitability | -114.1% | -14.4% | Higher Margin | AYTU |
| Net Profit Margin Profitability | -162.3% | -24.8% | Higher Margin | AYTU |
| Return on Equity (ROE) Capital Efficiency | 0.0% | -52.5% | Higher ROE | AQST |
| 52-Week Range Position Momentum | 22% ($3โ$7) | 5% ($2โ$3) | Stronger Trend | AQST |
| Beta / 30D Volatility Risk Regime | 0.87ฮฒ ยท 56% Vol | 0.65ฮฒ ยท 35% Vol | Lower Realized Risk | AYTU |
| Unified Institutional Score Composite Signal | 59.4 / 100 (HOLD) | 48.9 / 100 (HOLD) | Higher Composite | AQST |